One of the newest consortia we are part of is TRANSGEN.
In this consortium, CMN PIs team up colleagues from the UZA-UAntwerp Center of Medical Genetics to advance the translation of genomic and epigenomic insights into novel biomarkers and innovative therapies.
#CMNcohorts #CMNconsortia
Spotlight on Solve-RD: a consortium solving the unsolved in rare diseases 👇
Sarah Weckhuysen and Vincent Timmerman contribute to Solve-RD, a pan-European effort uniting ERNs, clinicians, patient groups, and -omics experts to crack undiagnosed rare diseases.
#CMNcohorts #CMNconsortia
The European Alzheimer & Dementia Biobank (EADB) unites cohorts across 18 countries to decode the genetics of Alzheimer’s disease. https://eadb.eu/
At CMN, the @sleegerslab.bsky.social plays a leading role, with postdoc Fahri Küçükali as our in-house EADB specialist.
#CMNcohorts #CMNconsortia
Happy anniversary to the 1,000 Healthy Elderly Study! 🎂
On this day last year, we included our very first participant (again). Today we’re at 196 re-inclusions, and on track to hit 200 by the end of the week. 💪
A special thank you today to our study nurse, Sofie Van de kerckhoven! 🥳
#CMNcohorts
Next up in our #CMNcohorts #CMNconsortia series, we spotlight a collaboration between the @sleegerslab.bsky.social and Dietmar Thal at KU Leuven: a post-mortem brain cohort, now paired with genetic characterization, and transcriptomic profiling underway.
We’ve built our strategy around consortia-driven science, where our own expertise plugs into global networks, and local patient data fuels international discovery. From genetics to biomarkers, there’s power in numbers.
https://beakon.ghost.io/united-in-purpose/
#CMNcohorts #CMNconsortia
